What SentiAR does

SentiAR is a St. Louis-based digital health and medical device company founded in 2017 that develops augmented reality (AR) visualization technology for intraprocedural clinical use in cardiac electrophysiology. Its flagship product, CommandEP, is the first FDA-cleared holographic cardiac ablation guidance system, providing electrophysiologists with real-time, interactive 3D holographic visualization of patient heart anatomy and electroanatomic mapping data during catheter ablation procedures. The platform runs on Microsoft HoloLens hardware and features a proprietary gaze-dwell control interface that allows physicians to manipulate the display hands-free while maintaining sterility; reported clinical metrics include up to 50% improvement in localization accuracy and a reduction in verbal commands from 1.7 to 0.17 per target point.

The company was co-founded by Dr. Jennifer Avari Silva (CMO, a leading pediatric electrophysiologist at Washington University), Dr. Jonathan Silva (CTO, biomedical engineering faculty), and Michael Southworth (VP of Technology, ex-Boeing and JHUAPL). Its R&D leadership includes Dr. Sharif Razzaque (Director of R&D), a 25-year AR/VR medical veteran who previously held senior roles at Microsoft Mixed Reality and Medtronic and is an inventor on over 20 Medical XR patent applications. SentiAR generates revenue through enterprise hardware sales of the CommandEP system combined with recurring software licensing to hospitals and cardiac catheterization labs, distributed via direct enterprise field sales. Named commercial customers to date include The Valley Hospital in New Jersey, which became the first in the state to use the platform in July 2024, marking the company's transition into early commercial-stage operations.

Name

SentiAR

Legal name

SentiAR, Inc.

Website

https://sentiar.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Cardiac Electrophysiology Visualization Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Electrophysiology Mapping & Ablation Systems (HLAHAFAD)

akta.pro secondary industries

Electrophysiology (Heart Rhythm) (HLAKABAC), Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Cardiac ablation guidance
• Augmented reality surgery
• Electrophysiology visualization
• Holographic medical imaging
• Interventional cardiology software

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D

Revenue model

1. CommandEP System: Sale and licensing of the CommandEP augmented reality system to hospitals and cardiac catheterization labs for use during electrophysiology procedures. The system combines proprietary software with Microsoft HoloLens hardware.
2. Software Licensing: Ongoing software licensing and updates for the AR visualization platform used during cardiac ablation procedures

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

SentiAR develops and sells CommandEP, an FDA 510(k)-cleared augmented reality visualization system for cardiac electrophysiology procedures. The platform ingests real-time data from catheters and 3D electroanatomic mapping systems to render interactive 3D holographic displays of patient heart anatomy, which electrophysiologists control hands-free via gaze commands on Microsoft HoloLens hardware during ablation procedures.

Product overview

SentiAR offers a single unified product called CommandEP, an augmented reality visualization platform designed for cardiac electrophysiology procedures. The system integrates real-time data from catheters and 3D electroanatomic mapping systems to generate holographic 3D visuals of the patient's heart anatomy, allowing physicians hands-free control via gaze commands during ablation procedures. The platform runs on Microsoft HoloLens hardware and was cleared by the FDA in September 2020 as the first holographic cardiac ablation guidance system.

Differentiator

Problem solved

Functional benefit

Brands

• CommandEP: Flagship augmented reality system for cardiac ablation procedures that creates interactive 3D visuals using real-time data from catheters and 3D electroanatomic mapping systems
• ELVIS (Enhanced Electrophysiology Visualization and Interactive System)

Products and services

• CommandEP Augmented reality visualization system that creates interactive 3D holographic displays of patient heart anatomy and electroanatomic mapping data in real-time during cardiac ablation procedures, providing hands-free gaze-controlled visualization to improve procedural accuracy. Designed for electrophysiologists and interventional cardiologists performing cardiac ablation procedures (e.g., atrial fibrillation treatment) at hospitals and cardiac catheterization labs.

Quantifiable outcome

• Localization accuracy improved by up to 50% within the heart
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• The Valley HospitalflagshipStrategic or Co-development PartnerThe Valley Hospital in New Jersey became the first hospital to perform a cardiac ablation procedure using SentiAR's holographic guidance platform in July 2024, marking the first commercial clinical use of the technology.
• Washington University in St. LouiscoreStrategic or Co-development PartnerSentiAR co-founders Dr. Jennifer Avari Silva and Dr. Jonathan Silva are affiliated with Washington University. The company maintains research collaboration through academic partnerships for clinical trials and product development. Dr. Jonathan Silva is an Assistant Professor of Biomedical Engineering at Washington University.
• MicrosoftcoreTechnology or IntegrationSentiAR uses Microsoft HoloLens as the delivery platform for its CommandEP augmented reality software. The company leverages Microsoft's mixed reality hardware technology for medical visualization applications.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• GE HealthCare: Sells cardiology imaging systems, cath-lab integration, and intra-procedural visualization tools used during cardiac ablation. Comparable broad incumbent with the resources to add AR visualization layers to its cardiology workflow stack.
• Philips Healthcare: Major vendor of cath-lab and EP interventional imaging equipment (Azurion, EchoNavigator). Comparable as a broad incumbent whose cath-lab visualization and image-guidance portfolio could overlap with SentiAR's hands-free intra-procedural visualization.
• Boston Scientific: Makes the Rhythmia HDx mapping system and a broad portfolio of cardiac ablation catheters. CEO Berk Tas previously worked at Boston Scientific, and the company is one of the three dominant EP mapping-and-ablation vendors whose installed base SentiAR's CommandEP is designed to overlay.
• Abbott: Owns the EnSite X EP navigation and mapping system used in cardiac ablation procedures alongside CARTO and Rhythmia. As an EP-mapping incumbent with broad cardiology device franchises, Abbott is a directly comparable large peer whose mapping system feeds the same procedure workflows SentiAR visualizes.
• Medtronic: Global medtech incumbent and owner of the CARTO 3D electroanatomic mapping system that CommandEP integrates with during cardiac ablation. Medtronic also has interventional imaging and mixed-reality investments, making it the most strategically significant incumbent — both as a data partner and a potential competitor.

Emerging players

• Proprio Vision: Light-field and AR visualization for spine surgery using headset hardware. Comparable emerging clinical AR visualization company with a similar hospital-procurement GTM and focus on intra-procedural 3D anatomical display.
• FundamentalVR: Provides HapticVR surgical training and education simulations using VR headsets. Comparable as an emerging clinical XR company with overlapping physician users in EP and cardiac surgery, though focused on training rather than live intra-procedural visualization.
• HeartVista: AI-guided cardiac MRI acquisition software for diagnostic cardiology. Comparable emerging cardiac-imaging software company serving the same electrophysiology and cardiology departments that purchase CommandEP, though focused on diagnostic imaging rather than intra-procedural visualization.
• ImmersiveTouch: Develops VR/AR simulation, planning, and visualization tools for surgery and interventional procedures. Comparable emerging clinical XR company with similar hospital and physician channels and an adjacent product positioning around surgical visualization.

Direct peers

• Surgical Theater: Provides 360° VR/AR surgical visualization for neurosurgery and other complex procedures using headsets. Closest direct peer to SentiAR in clinical extended-reality visualization, with comparable enterprise-medtech GTM and hospital-catheterization-lab orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sentiarco
• LinkedInlinkedin.com/company/sentiar

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds11 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SentiAR